Francesco Del Giudice | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Performance of Node-RADS scoring system for a standardized assessment of regional lymph nodes in bladder cancer patients	CANCERS	2023
Seeing is believing: state of the art Imaging of bladder cancer	SEMINARS IN RADIATION ONCOLOGY	2023
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study	THE JOURNAL OF UROLOGY	2023
Editorial commentary on: "Reduced vs full-dose BCG therapy in bladder cancer: A systematic review and meta-analysis"	ACTAS UROLÓGICAS ESPAÑOLAS	2023
The Risk of Cardiovascular and Cerebrovascular Disease in Men With a History of Priapism	THE JOURNAL OF UROLOGY	2023
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery	PROSTATE CANCER AND PROSTATIC DISEASES	2023
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review	ASIAN JOURNAL OF UROLOGY	2023
Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation	CANCERS	2023
Mid-term outcomes of minimally invasive infrapubic approach for inflatable penile prosthesis implantation: A single-center study and literature review	ANDROLOGY	2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors	WORLD JOURNAL OF UROLOGY	2023
Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the Literature	CANCERS	2023
Long term follow-up outcomes of pelvic floor rehabilitation in subjects suffering from lifelong premature ejaculation: Retrospective multicentre study	EUROPEAN UROLOGY. SUPPLEMENTS	2023
Investigating the role of the prostate multiparametric magnetic resonance imaging sequences quality on biopsies’ outcomes	EUROPEAN UROLOGY. SUPPLEMENTS	2023
Trends and incidence of reported events associated with ureteral stents: An analysis of the food and drug administration’s manufacturer and user facility device experience database	EUROPEAN UROLOGY. SUPPLEMENTS	2023
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques	DIAGNOSTICS	2023
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement	DIAGNOSTICS	2023
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS	2023
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review	THERAPEUTIC ADVANCES IN UROLOGY	2023
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis	MINERVA UROLOGY AND NEPHROLOGY	2023

1
2
3
4
5
6
7
8
9
seguente ›
ultima »

ERC

LS4_12

Interessi di ricerca

Genito Urinary Oncology
Minimally Invasive Robotic-Assisted Urologic Surgery
Urothelial Solid Neoplasms
Non-Muscle Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Upper Tract Urothelial Carcinomas

Progetti di Ricerca

Magnetic Resonance Imaging-Targeted Biopsy for Primary Detection of Prostate Cancer: Magnetic Resonance Imaging (MRI) In-Bore versus MRI-Trans-rectal ultrasound (TRUS) Fusion Technique
Co-expression of Programmed Death Ligand 1 (PD-L1) and markers of Epithelial-Mesenchymal Transition (EMT) on Circulating Tumor Cells (CTCs): a possible immune escape mechanism in urothelial carcinomas of the urinary bladder.